See also this year's filing and all EDGAR filings for this company.
PDF Report 0000899866_2016_Alexion_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000899866, Alexion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,425,349,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 9,755,799,000 |
| 2 | PropertyPlantAndEquipmentNet | 697,025,000 |
| 3 | remainder_Assets | 255,057,000 |
| 4 | LiabilitiesCurrent | 718,250,000 |
| 5 | LiabilitiesNoncurrent | 3,354,643,000 |
| 6 | remainder_Liabilities | 801,721,000 |
| 7 | CostOfGoodsAndServicesSold | 233,089,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,179,723,320 |
| 9 | ResearchAndDevelopmentExpense | 1,539,455,612 |
| 10 | remainder_Expenses | 714,799,267 |
| 11 | remainder_Revenues | 3,136,530,710 |
| 12 | remainder_NetIncome | 8,078,180 |
| 13 | remainder_ComprehensiveNetIncome | 61,493,466 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 13,133,230,000 |
| 1 | Liabilities | 4,874,614,000 |
| 2 | Expenses | 3,667,067,199 |
| 3 | Revenues | 3,136,530,710 |
| 4 | StockholdersEquity | 8,258,616,000 |
| 5 | NetIncome | -522,458,309 |
| 6 | ComprehensiveNetIncome | -491,711,576 |
| 7 | BaseVar | 12,440,506,778 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.94 |
| 9 | EconomicCapitalRatio | 2.99 |
Edgar->Model Mapping
Feature Distribution
Change over Time
